Cullinan Therapeutics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Cullinan Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $31.55. The average 1-year stock price forecast is 130.29% higher than the current stock price, while the lowest is $24 (+75.18%) and the highest is $38 (+177.37%).

Price Target: $31.55 (+130.29%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$24	$31.55	$30	$38
Change	+75.18%	+130.29%	+118.98%	+177.37%

Analyst Ratings

The average analyst rating for Cullinan Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	11	11	11	11	11
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	12	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Buy Reiterates $38	Buy	Reiterates	$38	+177.37%	Jun 11, 2026
Marc Frahm TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 11, 2026
Robert Driscoll Wedbush	Wedbush	Buy Maintains $37	Buy	Maintains	$37	+170.07%	Jun 11, 2026
Kaveri Pohlman Clear Street	Clear Street	Buy Maintains $33 → $46	Buy	Maintains	$33 → $46	+235.77%	Jun 10, 2026
Boris Peaker JonesTrading	JonesTrading	Buy Maintains $36	Buy	Maintains	$36	+162.77%	Jun 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

9.23M

Revenue Next Year

44.60M

from 9.23M

382.93%

from 9.23M

EPS This Year

-3.15

from -3.36

EPS Next Year

-2.53

from -3.15

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	18.94M	-	-	-	-	9.23M
Operating Income	-67.95M	-132.14M	-190.65M	-196.92M	-241.65M	-214.19M
Net Income	-65.57M	111.21M	-153.16M	-167.38M	-219.88M	-204.35M
EPS	-	-	-	-	-3.36	-3.15
Free Cash Flow	-24.64M	-47.60M	-88.76M	-84.86M	-100.28M	-172.00M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	47.3M
Avg	9.2M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	1,463.0%
Avg	382.9%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-2.48
Avg	-3.15
Low	-3.54

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-